| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/05/2001 | US20010006816 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006815 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006814 Chemical modification |
| 07/05/2001 | US20010006801 Active ribozyme |
| 07/05/2001 | US20010006799 Histidine kinase polypeptides |
| 07/05/2001 | US20010006798 Novel FtsL |
| 07/05/2001 | US20010006797 Transfection cell with genetic vector |
| 07/05/2001 | US20010006796 Nucleic acids encoding variant human vectors |
| 07/05/2001 | US20010006786 DNA chip and its preparation |
| 07/05/2001 | US20010006781 Cancer cells capable of tumorigenesis but incapable of infiltration and metastasis, process for preparing the same, and method for screening gene relating to metastasis by using the same |
| 07/05/2001 | US20010006779 Isolated gene coding polypeptide |
| 07/05/2001 | US20010006778 Methods for identifying compounds that bind to a target |
| 07/05/2001 | US20010006681 Chemokine inhibition of immunodeficiency virus |
| 07/05/2001 | US20010006642 Delivering antigens or biologically active polypeptides to a subject in need of same by administering to the subject a non-invasive or non-pathogenic bacterium which expresses the antigens or polypeptides |
| 07/05/2001 | US20010006629 Recombinant adenoviral vector and methods of use |
| 07/05/2001 | DE19960924A1 Amphiphile Polyamine, deren Anwendungen und Verfahren zu ihrer Synthese Amphiphilic polyamines, their applications and methods for their synthesis |
| 07/05/2001 | DE19959950A1 Pflanze mit erhöhter Pathogenresistenz Plant with increased pathogen |
| 07/05/2001 | CA2685457A1 Insecticidal proteins from bacillus thuringiensis |
| 07/05/2001 | CA2406668A1 High affinity tcr proteins and methods |
| 07/05/2001 | CA2397952A1 Method for treatment of canine distemper |
| 07/05/2001 | CA2397710A1 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2396029A1 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope |
| 07/05/2001 | CA2396010A1 Detection of single nucleotide polymorphisms |
| 07/05/2001 | CA2395957A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 07/05/2001 | CA2395950A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | CA2395920A1 Method for generation of longer cdna fragments from sage tags for gene identification |
| 07/05/2001 | CA2395839A1 Gene therapy for congestive heart failure |
| 07/05/2001 | CA2395544A1 Method of achieving persistent transgene expression |
| 07/05/2001 | CA2395535A1 Method for the production of vitamin a |
| 07/05/2001 | CA2395529A1 Modified dhps genes |
| 07/05/2001 | CA2395524A1 Chemotherapeutant screening method |
| 07/05/2001 | CA2395492A1 Method and apparatus for targeting localised electroporation |
| 07/05/2001 | CA2395490A1 Repressible sterility of animals |
| 07/05/2001 | CA2395454A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | CA2395442A1 Methods and materials relating to gene expression |
| 07/05/2001 | CA2395439A1 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
| 07/05/2001 | CA2395423A1 P. gingivalis antigenic composition |
| 07/05/2001 | CA2395382A1 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | CA2395335A1 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | CA2395320A1 Therapeutic uses of lna-modified oligonucleotides |
| 07/05/2001 | CA2395299A1 Method for producing 6-0-.alpha.-d-glucopyranosyl-d-sorbite |
| 07/05/2001 | CA2395285A1 Production of heterologous proteins |
| 07/05/2001 | CA2395276A1 Identification of novel splice variants of the human catalytic subunit c.beta. of camp-dependent protein kinase and the use thereof |
| 07/05/2001 | CA2395273A1 A novel isoform of human camp-dependent protein kinase, c.alpha.-s, localizes to sperm midpiece and the use thereof |
| 07/05/2001 | CA2395242A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395003A1 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394807A1 Gibberellin 2.beta.-hydroxylase genes of rice and uses thereof |
| 07/05/2001 | CA2394758A1 Histidine-containing copolymers enhance pharmaceutical agent delivery |
| 07/05/2001 | CA2394748A1 Optimized minigenes and peptides encoded thereby |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/05/2001 | CA2394174A1 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | CA2392703A1 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | CA2365224A1 Methods for producing enantiomerically pure .alpha.-substituted carboxylic acids |
| 07/05/2001 | CA2363180A1 Use of lithium (li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/04/2001 | EP1113082A2 Amplification capture assay |
| 07/04/2001 | EP1113081A1 Implication of a known gene named CP2/LSF/LBP-1 in Alzheimer's disease |
| 07/04/2001 | EP1113080A2 Personal gene library |
| 07/04/2001 | EP1113079A2 A method for typing polymorphisms of bovine MHC class II genes |
| 07/04/2001 | EP1113078A1 Methods for extracting similar expression patterns and related biopolymers |
| 07/04/2001 | EP1113075A1 Dna fragment having promoter function |
| 07/04/2001 | EP1113074A1 Actinobacillus pleuropneumoniae outer membrane protein and its use |
| 07/04/2001 | EP1113073A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 07/04/2001 | EP1113021A2 Polyamide-oligonucleotide derivatives, their production and use |
| 07/04/2001 | EP1113020A2 Nucleosides and oligonucleotides containing boron clusters |
| 07/04/2001 | EP1112385A1 Artificial long terminal repeat vectors |
| 07/04/2001 | EP1112384A1 Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin d receptor gene |
| 07/04/2001 | EP1112383A1 Method for determining susceptibility to bone damage by screening polymorphisms in the vitamin d receptor gene |
| 07/04/2001 | EP1112382A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 07/04/2001 | EP1112381A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/04/2001 | EP1112380A1 Method and kit for detecting intrachromosome imbalance in inter phase nuclei and their applications |
| 07/04/2001 | EP1112379A1 NOVEL AMPLICON IN THE 20q13 REGION OF HUMAN CHROMOSOME 20 AND USES THEREOF |
| 07/04/2001 | EP1112375A1 Biosensor |
| 07/04/2001 | EP1112372A1 Alternatively targeted adenovirus |
| 07/04/2001 | EP1112371A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/04/2001 | EP1112370A1 Maize sina orthologue-1 and uses thereof |
| 07/04/2001 | EP1112369A2 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES |
| 07/04/2001 | EP1112368A1 Use of protein kinase kiaa0551 as pharmaceutical |
| 07/04/2001 | EP1112367A2 Agents and methods for modifying the glutamine metabolism in plants, especially in sugar beet |
| 07/04/2001 | EP1112366A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112364A2 Stomach polypeptide zsig28 |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 07/04/2001 | EP1112360A1 Ecdysone receptors and methods for their use |
| 07/04/2001 | EP1112359A2 Enhanced functional expression of g protein-coupled receptors |
| 07/04/2001 | EP1112358A2 Dna sequence encoding oncofetal ferritin protein |
| 07/04/2001 | EP1112357A1 Putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits, cacnglike2 (calcium channel gamma like 2) |
| 07/04/2001 | EP1112356A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancers |
| 07/04/2001 | EP1112355A1 Gene and protein libraries and methods relating thereto |
| 07/04/2001 | EP1112354A1 Novel protein kinase molecules and uses therefor |
| 07/04/2001 | EP1112353A2 Recombinant protein production in urine |
| 07/04/2001 | EP1112351A2 Polymerase chimeras |
| 07/04/2001 | EP1112348A2 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering |
| 07/04/2001 | EP1112344A2 Bacterial strains for the production of 2-keto-l-gulonic acid |
| 07/04/2001 | EP1112286A1 Secreted proteins and polynucleotides encoding them |